Kymera Therapeutics, Inc. (KYMR) SEC filings
KYMR SEC filings moved a median of +1.59% by the close. KYMR SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the KYMR overview →
57 measured KYMR SEC filing events.
Where these KYMR SEC filings landedvs 57 measured KYMR SEC filing reactions
| Middle 50% of KYMR SEC filing reactions | -2.71% to +5.54% |
|---|---|
| Median reaction (to close) | +1.59% |
| Measured reactions | 57 |
Point-in-time · zero look-ahead
Half of the 57 KYMR SEC filing events with a measured close landed between -2.71% and +5.54%; 61% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Kymera Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.67% | +0.59% | |
| Form 8-K Kymera Therapeutics, For: Aug 05 | SEC filing · Form 8-K | +0.67% | +0.59% | |
| Form 8-K Kymera Therapeutics, For: Jul 27 | SEC filing · Form 8-K | -0.64% | -2.40% | |
| Form 8-K Kymera Therapeutics, For: Jun 25 | SEC filing · Form 8-K | +12.08% | +7.04% | |
| Form 8-K Kymera Therapeutics, For: Jun 24 | SEC filing · Form 8-K | +12.08% | +7.04% | |
| Form 8-K Kymera Therapeutics, For: Jun 05 | SEC filing · Form 8-K | +0.59% | +2.71% | |
| Form 10-Q Kymera Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -1.11% | -5.06% | |
| Form 8-K Kymera Therapeutics, For: Apr 30 | SEC filing · Form 8-K | -1.11% | -5.06% | |
| Form ARS Kymera Therapeutics, For: Dec 31 | SEC filing · Form ARS | -1.11% | -5.06% | |
| Form DEF 14A Kymera Therapeutics, For: Jun 24 | SEC filing · Form DEF | -1.11% | -5.06% | |
| Form DEFA14A Kymera Therapeutics, | SEC filing · Form DEFA14A | -1.11% | -5.06% | |
| Form 8-K Kymera Therapeutics, For: Mar 25 | SEC filing · Form 8-K | +2.55% | +0.95% | |
| Form 10-K Kymera Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +5.92% | +10.50% | |
| Form 8-K Kymera Therapeutics, For: Feb 26 | SEC filing · Form 8-K | +5.92% | +10.50% | |
| Form S-8 Kymera Therapeutics, | SEC filing · Form S-8 | +5.92% | +10.50% | |
| Form 8-K Kymera Therapeutics, For: Jan 13 | SEC filing · Form 8-K | -0.19% | +1.59% | |
| Form 8-K Kymera Therapeutics, For: Dec 08 | SEC filing · Form 8-K | +0.31% | -3.23% | |
| Form 8-K Kymera Therapeutics, For: Dec 08 | SEC filing · Form 8-K | +5.97% | +5.75% | |
| Form 10-Q Kymera Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +7.56% | +7.37% | |
| Form 8-K Kymera Therapeutics, For: Nov 04 | SEC filing · Form 8-K | +7.56% | +7.37% | |
| Form 8-K Kymera Therapeutics, For: Aug 27 | SEC filing · Form 8-K | +0.42% | +7.26% | |
| Form 10-Q Kymera Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -1.25% | -1.26% | |
| Form 8-K Kymera Therapeutics, For: Aug 11 | SEC filing · Form 8-K | -1.25% | -1.26% | |
| Form 8-K Kymera Therapeutics, For: Jun 25 | SEC filing · Form 8-K | +0.19% | -2.28% | |
| Form 8-K Kymera Therapeutics, For: Jun 25 | SEC filing · Form 8-K | -1.28% | +2.00% | |
| Form 8-K Kymera Therapeutics, For: Jun 02 | SEC filing · Form 8-K | -2.58% | +7.83% | |
| Form 10-Q Kymera Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -1.62% | -10.61% | |
| Form 8-K Kymera Therapeutics, For: May 09 | SEC filing · Form 8-K | -1.62% | -10.61% | |
| Form ARS Kymera Therapeutics, For: Dec 31 | SEC filing · Form ARS | +1.90% | +3.41% | |
| Form DEF 14A Kymera Therapeutics, For: Jun 25 | SEC filing · Form DEF | +1.90% | +3.41% | |
| Form DEFA14A Kymera Therapeutics, | SEC filing · Form DEFA14A | +1.90% | +3.41% | |
| Form 8-K Kymera Therapeutics, For: Mar 03 | SEC filing · Form 8-K | +3.54% | +5.54% | |
| Form 10-K Kymera Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +1.06% | -10.05% | |
| Form 8-K Kymera Therapeutics, For: Feb 27 | SEC filing · Form 8-K | +1.06% | -10.05% | |
| Form S-8 Kymera Therapeutics, | SEC filing · Form S-8 | +1.06% | -10.05% | |
| Form 8-K Kymera Therapeutics, For: Jan 14 | SEC filing · Form 8-K | +1.96% | +5.47% | |
| Form 10-Q Kymera Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.94% | +3.17% | |
| Form 8-K Kymera Therapeutics, For: Oct 31 | SEC filing · Form 8-K | +0.94% | +3.17% | |
| Form S-3ASR Kymera Therapeutics, | SEC filing · Form S-3ASR | +0.94% | +3.17% | |
| Form 8-K Kymera Therapeutics, For: Aug 19 | SEC filing · Form 8-K | +0.83% | +3.47% | |
| Form 10-Q Kymera Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -2.00% | -11.33% | |
| Form 8-K Kymera Therapeutics, For: Aug 07 | SEC filing · Form 8-K | -2.00% | -11.33% | |
| Form 8-K Kymera Therapeutics, For: Jul 08 | SEC filing · Form 8-K | +1.99% | +10.57% | |
| Form 8-K Kymera Therapeutics, For: Jun 18 | SEC filing · Form 8-K | -0.48% | +1.52% | |
| Form 10-Q Kymera Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -1.82% | +0.36% | |
| Form 8-K Kymera Therapeutics, For: May 02 | SEC filing · Form 8-K | -1.82% | +0.36% | |
| Form ARS Kymera Therapeutics, For: Dec 31 | SEC filing · Form ARS | -1.57% | -2.71% | |
| Form DEF 14A Kymera Therapeutics, For: Jun 18 | SEC filing · Form DEF | -1.57% | -2.71% | |
| Form DEFA14A Kymera Therapeutics, | SEC filing · Form DEFA14A | -1.57% | -2.71% | |
| Form 8-K Kymera Therapeutics, For: Mar 28 | SEC filing · Form 8-K | -3.16% | -2.28% | |
| Form 10-K Kymera Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +1.31% | +1.73% | |
| Form 8-K Kymera Therapeutics, For: Feb 22 | SEC filing · Form 8-K | +1.31% | +1.73% | |
| Form S-8 Kymera Therapeutics, | SEC filing · Form S-8 | +1.31% | +1.73% | |
| Form 8-K Kymera Therapeutics, For: Jan 04 | SEC filing · Form 8-K | -5.58% | -2.04% | |
| Form 8-K Kymera Therapeutics, For: Jan 04 | SEC filing · Form 8-K | -2.56% | +17.94% | |
| Form 10-Q Kymera Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +5.22% | +19.72% | |
| Form 8-K Kymera Therapeutics, For: Nov 02 | SEC filing · Form 8-K | +5.22% | +19.72% |
Keep exploring
More KYMR: earnings → · analyst actions → · KYMR overview →